Showing results (1461-1470 of 1,572) with videos related to
Sort By:
Pageof 158
MMWR Supplements|September 2, 2011
Mental illness surveillance among adults in the United StatesWilliam C Reeves, Tara W Strine, Laura A Pratt, et al.Human Genomics|December 14, 2011
In-silico human genomics with GeneCardsGil Stelzer, Irina Dalah, Tsippi Iny Stein, et al.JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.Database : the Journal of Biological Databases and Curation|August 7, 2010
GeneCards Version 3: the human gene integratorMarilyn Safran, Irina Dalah, Justin Alexander, et al.Cancer Investigation|January 12, 2005
Low overexpression of HER-2/neu in advanced colorectal cancer limits the usefulness of trastuzumab (Herceptin) and irinotecan as therapy. A phase II trialRamesh K Ramanathan, Jimmy J Hwang, William C Zamboni, et al.Cancer Chemotherapy and Pharmacology|June 27, 2023
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label studyMats Någård, Mei-Lin Ah-See, James Strauss, et al.The American Journal of Sports Medicine|May 7, 2009
Differences in physician and patient ratings of items used to assess hip disordersRobRoy L Martin, Nicholas G Mohtadi, Marc R Safran, et al.The Journal of Experimental Medicine|June 20, 2007
A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and plateletsRonit Pasvolsky, Sara W Feigelson, Sara Sebnem Kilic, et al.Spine|July 22, 2022
A Short-Term Assessment of Lumbar Sagittal Alignment Parameters in Patients Undergoing Anterior Lumbar Interbody FusionMark J Lambrechts, Nicholas Siegel, Brian A Karamian, et al.Instructional Course Lectures|August 15, 2019
Incorporating Hip Arthroscopy Into A PracticeMarc R Safran, Asheesh Bedi, J W Thomas Byrd, et al.Pageof 158